Roxas inakusahang namumulitika sa usapin ng gamot
MANILA – Dapat na umanong itigil ni Senador Manuel Roxas II ang paghahanap ng masisisi kung bakit hindi bumababa ang presyo ng gamot kahit isang taon na ang lumipas mula ng gawing batas ang Cheaper Medicines Act.
Sa panayam ng media, sinabi ni Iloilo Rep. Ferjenel Biron, senior vice chairman ng House committee on health, na si Roxas ang nagpilit na alisin ang probisyon na nagtatakda ng automatic price regulation sa Republic Act No. 9502, o Universally Accessible, Cheaper and Quality Medicines Act.
“It was Roxas who pushed for the exclusion of the ‘heart and soul’ Republic Act No. 9502 which will impose mandatory price regulation in the pharmaceuticals industry," paliwanag ni Biron, may-akda ng bersyon ng Kamara de Representantes sa cheaper medicine bill.
“Sen. Roxas should not blame President (Gloria) Arroyo for the failure of the Cheaper Medicines Law. He should blame himself because he killed the law," idinagdag ng kongresista.
Una rito, inakusahan ni Roxas, awtor ng bersyon ng Senado ng cheaper medicine bill, na nakipagsabwatan si Arroyo sa mga dayuhang pharmaceutical companies kaya hindi maibaba ang presyo ng ilang piling gamot.
Hinamon ng senador si Arroyo na pirmahan ang executive order na nagsasaad ng maximum retail price upang maipababa ang presyo ng 22 uri ng gamot na kasama sa itinatakda ng RA 9502.
“Definitely it is pure politics. Wild accusation! People are not that stupid to believe him. I was in the meeting when President Arroyo gave the multinational pharmaceutical companies 10 days to bring down their prices or she will be force to sign the EO.
– Manila Rep. Benny Abante
Ngunit ayon kay Biron, hindi umano magiging problema ang MRT kung tinanggap ni Roxas at naisama sa RA 9502 ang iminungkahi ng mga kongresista na ipasok ang probisyon ng mandatory price regulation.
“The thought of inviting President Arroyo to the oversight is pointless. Sen. Roxas should realize that it was him who blocked the mandatory price regulation provision of the Cheaper Medicines Law. He gave it up to the sole discretion of the President upon the recommendation of the Health Secretary," ayon sa kongresista.
Sinabi ni Roxas na kung maipapatupad ang EO, bababa ang presyo ng mga gamot na anti-hypertensive drug Norvasc (P22.50 mula sa P44.50); anti-diabetes Diamicron (P7.35 mula sa P14.75); antibiotic; Zithromax (P149.37 mula sa P298.75); at antibiotic Augmentin suspension 60 ml (sa P179.50 mula P359).
Idinagdag ni dating Iloilo Rep. Rolex Suplico, nagsulong ng panukala noong 11th at 12th Congress na sadyang tinutulan ni Roxas ang pagbuo ng Drug Price Regulatory Board.
“I was sole author of the cheaper medicines bill in the 11th Congress. I re-filed it in the 12th Congress. Rep. Biron joined me in the 13th Congress.. Kami ay para sa creation ng Drug Price Regulatory Board. Mar was against it. Ang kanya ay parallel importation. Kaya inabolish ni Mar ang Board at ibinigay ang kapangyarihan sa Presidente," paliwanag ni Suplico, kasalukuyang vice governor ng Iloilo.
Naniniwala naman si Manila Rep. Bienvenido Abante, na ginagamit ni Roxas ang usapin sa presyo ng gamot at inaakusahan ang Malacanang na nakikipagsabwatan sa mga drug companies para maitaas ang rating bilang presidentiables.
“Definitely it is pure politics. Wild accusation! People are not that stupid to believe him. I was in the meeting when President Arroyo gave the multinational pharmaceutical companies 10 days to bring down their prices or she will be force to sign the EO," kuwento ni Abante.
Kinatigan naman ni Nueva Ecija Rep. Rodolfo Antonino ang pananaw ni Abante tungkol sa pag-akusa ni Roxas tungkol sa alegasyon ng sabwatan para hindi maging epektibo ang RA 9502.
"Lahat gagamitin para malagay sa media. Election na. Puro sila away na lang, maski nasa tama aawayin pa rin nila. The Cheaper Medicine Law will be implemented as soon as all the data are submitted to DOH (Department of Health) and DTI (Department of Trade and Industry)," pahayag ni Antinino. - GMANews.TV
Sa panayam ng media, sinabi ni Iloilo Rep. Ferjenel Biron, senior vice chairman ng House committee on health, na si Roxas ang nagpilit na alisin ang probisyon na nagtatakda ng automatic price regulation sa Republic Act No. 9502, o Universally Accessible, Cheaper and Quality Medicines Act.
“It was Roxas who pushed for the exclusion of the ‘heart and soul’ Republic Act No. 9502 which will impose mandatory price regulation in the pharmaceuticals industry," paliwanag ni Biron, may-akda ng bersyon ng Kamara de Representantes sa cheaper medicine bill.
“Sen. Roxas should not blame President (Gloria) Arroyo for the failure of the Cheaper Medicines Law. He should blame himself because he killed the law," idinagdag ng kongresista.
Una rito, inakusahan ni Roxas, awtor ng bersyon ng Senado ng cheaper medicine bill, na nakipagsabwatan si Arroyo sa mga dayuhang pharmaceutical companies kaya hindi maibaba ang presyo ng ilang piling gamot.
Hinamon ng senador si Arroyo na pirmahan ang executive order na nagsasaad ng maximum retail price upang maipababa ang presyo ng 22 uri ng gamot na kasama sa itinatakda ng RA 9502.
“Definitely it is pure politics. Wild accusation! People are not that stupid to believe him. I was in the meeting when President Arroyo gave the multinational pharmaceutical companies 10 days to bring down their prices or she will be force to sign the EO.Ngunit ayon kay Biron, hindi umano magiging problema ang MRT kung tinanggap ni Roxas at naisama sa RA 9502 ang iminungkahi ng mga kongresista na ipasok ang probisyon ng mandatory price regulation.
“The thought of inviting President Arroyo to the oversight is pointless. Sen. Roxas should realize that it was him who blocked the mandatory price regulation provision of the Cheaper Medicines Law. He gave it up to the sole discretion of the President upon the recommendation of the Health Secretary," ayon sa kongresista.
Sinabi ni Roxas na kung maipapatupad ang EO, bababa ang presyo ng mga gamot na anti-hypertensive drug Norvasc (P22.50 mula sa P44.50); anti-diabetes Diamicron (P7.35 mula sa P14.75); antibiotic; Zithromax (P149.37 mula sa P298.75); at antibiotic Augmentin suspension 60 ml (sa P179.50 mula P359).
Idinagdag ni dating Iloilo Rep. Rolex Suplico, nagsulong ng panukala noong 11th at 12th Congress na sadyang tinutulan ni Roxas ang pagbuo ng Drug Price Regulatory Board.
“I was sole author of the cheaper medicines bill in the 11th Congress. I re-filed it in the 12th Congress. Rep. Biron joined me in the 13th Congress.. Kami ay para sa creation ng Drug Price Regulatory Board. Mar was against it. Ang kanya ay parallel importation. Kaya inabolish ni Mar ang Board at ibinigay ang kapangyarihan sa Presidente," paliwanag ni Suplico, kasalukuyang vice governor ng Iloilo.
Naniniwala naman si Manila Rep. Bienvenido Abante, na ginagamit ni Roxas ang usapin sa presyo ng gamot at inaakusahan ang Malacanang na nakikipagsabwatan sa mga drug companies para maitaas ang rating bilang presidentiables.
“Definitely it is pure politics. Wild accusation! People are not that stupid to believe him. I was in the meeting when President Arroyo gave the multinational pharmaceutical companies 10 days to bring down their prices or she will be force to sign the EO," kuwento ni Abante.
Kinatigan naman ni Nueva Ecija Rep. Rodolfo Antonino ang pananaw ni Abante tungkol sa pag-akusa ni Roxas tungkol sa alegasyon ng sabwatan para hindi maging epektibo ang RA 9502.
"Lahat gagamitin para malagay sa media. Election na. Puro sila away na lang, maski nasa tama aawayin pa rin nila. The Cheaper Medicine Law will be implemented as soon as all the data are submitted to DOH (Department of Health) and DTI (Department of Trade and Industry)," pahayag ni Antinino. - GMANews.TV
advertisement
advertisement
advertisement
